Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 3 of 3
  • Item
    Thumbnail Image
    Evaluation of the Nucleus Spectra 22 Processor and New Speech Processing Strategy (SPEAK) in postlinguistically deafened adults
    Whitford, Lesley A. ; Seligman, Peter M. ; Everingham, Colleen E. ; Antognelli, Trisha ; Skok, Marisa C. ; Hollow, Rodney D. ; Plant, Kerrie L. ; Gerin, Elvira S. ; Staller, Steve J. ; McDermott, Hugh J. ; Gibson, William R. ; Clark, Graeme M. ( 1995)
    A new speech processing strategy (SPEAK) has been compared with the previous Multipeak (MPEAK) strategy in a study with 24 postlinguistically deafened adults. The results show that performance with the SPEAK coding strategy was significantly better for 58.3% of subjects on closed-set consonant identification, for 33.3% of subjects on closed-set vowel identification and open-set monosyllabic word recognition, and for 81.8% of subjects on open-set sentence recognition in quiet and in competing noise (+ 10 dB signal-to-noise ratio). By far the largest improvement observed was for sentence recognition in noise, with the mean score across subjects for the SPEAK strategy twice that obtained with MPEAK.
  • Item
    Thumbnail Image
    Speech perception in children using the advanced Speak speech-processing strategy
    Cowan, R. S. C. ; Brown, C. ; Whitford, L. A. ; Galvin, K. L. ; Sarant, J. Z. ; Barker, E. J. ; Shaw, S. ; King, A. ; Skok, M. ; Seligman, P. M. ; Dowell, R. C. ; Everingham, C. ; Gibson, W. P. R. ; Clark, Graeme M. ( 1995)
    The Speak speech-processing strategy, developed by the University of Melbourne and commercialized by Cochlear Pty Limited for use in the new Spectra 22 speech processor, has been shown to provide improved speech perception for adults in both quiet and noisy situations. The present study evaluated the ability of children experienced in the use of the Multipeak (Mpeak) speech-processing strategy (implemented in the Nucleus Minisystem-22 cochlear implant) to adapt to and benefit from the advanced Speak speech-processing strategy (implemented in the Nucleus Spectra 22 speech processor). Twelve children were assessed using Mpeak and Speak over a period of 8 months. All of the children had over 1 year's previous experience with Mpeak, and all were able to score significantly on open-set word and sentence tests using the cochlear implant alone. Children were assessed with both live-voice and recorded speech materials, including Consonant-Nucleus-Consonant monosyllabic words and Speech Intelligibility Test sentences. Assessments were made in both quiet and in noise. Assessments were made at 3-week intervals to investigate the ability of the children to adapt to the new speech-processing strategy. For most of the children, a significant advantage was evident when using the Speak strategy as compared with Mpeak. For 4 of the children, there was no decrement in speech perception scores immediately following fitting with Speak. Eight of the children showed a small (10% to 20%) decrement in speech perception scores for between 3 and 6 weeks following the changeover to Speak. After 24 weeks' experience with Speak, 11 of the children had shown a steady increase in speech perception scores, with final Speak scores higher than for Mpeak. Only 1 child showed a significant decrement in speech perception with Speak, which did not recover to original Mpeak levels.
  • Item
    Thumbnail Image
    Evaluation of a new Spectral Peak coding strategy for the Nucleus 22 channel cochlear implant system
    Skinner, Margaret W. ; Clark, Graeme M. ; Whitford, Lesley A. ; Seligman, Peter M. ; Staller, Steven J. ; Shipp, David B. ; Shallop, Jon K. ; Everingham, Colleen ; Menapace, Christine M. ; Arndt, Patti L. ; Antogenelli, Trisha ; Brimacombe, Judith A. ; Pijl, Sipke ; Daniels, Paulette ; George, Catherine R. ; McDermott, Hugh J. ; Beiter, Anne L. ( 1994)
    Sixty-three postlinguistically deaf adults from four English-speaking countries participated in a 17-week field study of performance with a new speech coding strategy, Spectral Peak (SPEAK), and the most widely used strategy, Multipeak (MPEAK), both of which are implemented on wearable speech processors of the Nucleus 22 Channel Cochlear Implant System; MPEAK is a feature-extraction strategy, whereas SPEAK is a filterbank strategy. Subjects' performance was evaluated with an experimental design in which use of each strategy was reversed and replicated (ABAB). Average scores for speech tests presented sound-only at 70 dB SPL were higher with the SPEAK strategy than with the MPEAK strategy. For tests in quiet, mean scores for medial vowels were 74.8 percent versus 70.1 percent; for medial consonants, 68.6 percent versus 56.6 percent; for monosyllabic words, 33.8 percent versus 24.6 percent; and for sentences, 77.5 percent versus 67.4 percent. For tests in noise, mean scores for Four-Choice Spondees at +10 and +5 dB signal-to-noise ratio (S/N) were 88.5 percent versus 73.6 percent and 80.1 percent versus 62.3 percent, respectively; and for sentences at +15 dB, +10, and +5 dB S/N, 66.5 percent versus 43.4 percent, 61.5 percent versus 37.1 percent, and 60.4 percent versus 31.7 percent, respectively. Subjects showed marked improvement in recognition of sentences in noise with the new SPEAK filterbank strategy. These results agree closely with subjects' responses to a questionnaire on which approximately 80 percent reported they heard best with the SPEAK strategy for everyday listening situations.